Talk:Cinolazepam

Fatal overdose may occur when benzodiazepines are combined with other depressants such as opiates, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances. It is strongly discouraged to combine these substances, particularly in common to heavy doses.

This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

Cinolazepam
Chemical Nomenclature
Common names	Cinolazepam, Gerodorm
Systematic name	(RS)-3-[9-Chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile
Class Membership
Psychoactive class	Depressant
Chemical class	Benzodiazepine
Routes of Administration
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. ⇣ Oral Dosage Bioavailability 90–100% Threshold 20 mg Light 20 - 40 mg Common 40 - 80 mg Strong 80 - 200 mg Heavy 200 mg + Duration Total 6 hours+ Onset 30 - 60 minutes After effects 12 - 24 hours DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Gerodorm (Cinolazepam) 40 mg tablets

Summary sheet: Cinolazepam

Cinolazepam (trade name Gerodorm) is a a short-acting psychoactive drug of the benzodiazepine class which produces hypnotic, anxiolytic, sedative, muscle relaxant, anticonvulsant, and amnesic effects. Due to its strong sedative properties, it is primarily used as an hypnotic. Cinolazepam has an elimination half-life of approximately 9 hours, and is considered to be a short-acting benzodiazepine. It has a fast onset of action, with a peak blood level occurring 0.5 to 2 hours after oral administration.

At heavy doses, Cinolazepam has been anecdotally reported to produce atypical hallucinatory effects, like those of Zolpidem and Zopiclone, although to a lighter extent.

Legal issues

Cinolazepam is not approved for sale in the United States or Canada.